Literature DB >> 25262642

A comparison of inpatients with anxious depression to those with nonanxious depression.

Ching-Hua Lin1, Fu-Chiang Wang2, Shih-Chi Lin2, Cheng-Chung Chen1, Chun-Jen Huang3.   

Abstract

Anxiety symptoms are common for patients with major depressive disorder (MDD). Anxious depression has been considered MDD with high levels of anxiety symptoms. The objective of this study was to investigate the factors associated with anxious depression for Chinese inpatients with MDD. A total of 174 acutely ill patients were enrolled. Baseline demographic variables, suicide risk, depression severity, quality of life (QOL), and daily functional impairment were assessed. Those MDD patients with a 17-item Hamilton Depression Rating Scale (HAMD-17) anxiety/somatization factor score≥7 were defined as anxious depression. Logistic regression was employed to examine the factors associated with anxious depression. One hundred and forty-one (81.0%) of the subjects reported anxious depression. Patients with anxious depression were more likely to have melancholic features, to be older, to experience more severe depression, to be at greater risk of suicide, to have more pain, poorer quality of life, and more severe functional impairment. Anxious depression is common in inpatients with MDD. These findings suggest that anxious depression significantly differs from nonanxious depression on several clinically relevant variables. These data add to a growing body of evidence that anxious depression is a more complex presentation of depression.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anxious depression; Daily functioning; Melancholic features; Quality of life; Suicide

Mesh:

Year:  2014        PMID: 25262642     DOI: 10.1016/j.psychres.2014.08.048

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  11 in total

1.  Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys.

Authors:  R C Kessler; N A Sampson; P Berglund; M J Gruber; A Al-Hamzawi; L Andrade; B Bunting; K Demyttenaere; S Florescu; G de Girolamo; O Gureje; Y He; C Hu; Y Huang; E Karam; V Kovess-Masfety; S Lee; D Levinson; M E Medina Mora; J Moskalewicz; Y Nakamura; F Navarro-Mateu; M A Oakley Browne; M Piazza; J Posada-Villa; T Slade; M Ten Have; Y Torres; G Vilagut; M Xavier; Z Zarkov; V Shahly; M A Wilcox
Journal:  Epidemiol Psychiatr Sci       Date:  2015-02-27       Impact factor: 6.892

2.  Anxious depression as a clinically relevant subtype of pediatric major depressive disorder.

Authors:  Isabelle Häberling; Noemi Baumgartner; Sophie Emery; Paola Keller; Michael Strumberger; Kristin Nalani; Klaus Schmeck; Suzanne Erb; Silke Bachmann; Lars Wöckel; Ulrich Müller-Knapp; Brigitte Contin-Waldvogel; Bruno Rhiner; Susanne Walitza; Gregor Berger
Journal:  J Neural Transm (Vienna)       Date:  2019-08-27       Impact factor: 3.575

3.  Association between thyroid function and comorbid anxiety in first-episode and drug naïve patients with major depressive disorder.

Authors:  Wanqiu Yang; Miao Qu; Rui Jiang; XiaoE Lang; Xiang-Yang Zhang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-18       Impact factor: 5.760

4.  Prevalence of Comorbid Anxiety Disorders and Their Associated Factors in Patients with Bipolar Disorder or Major Depressive Disorder.

Authors:  Takeshi Inoue; Toshifumi Kimura; Yoshifumi Inagaki; Osamu Shirakawa
Journal:  Neuropsychiatr Dis Treat       Date:  2020-07-12       Impact factor: 2.570

5.  Anxiety symptoms in working patients with major depressive disorder treated with vortioxetine: associations with clinical and treatment outcomes in the AtWoRC study.

Authors:  Pratap Chokka; Holly Ge; Joanna Bougie; Anders Ettrup; Guerline Clerzius
Journal:  Ther Adv Psychopharmacol       Date:  2021-05-10

6.  Mediating Role of the Reward Network in the Relationship between the Dopamine Multilocus Genetic Profile and Depression.

Authors:  Liang Gong; Cancan He; Yingying Yin; Hui Wang; Qing Ye; Feng Bai; Yonggui Yuan; Haisan Zhang; Luxian Lv; Hongxing Zhang; Zhijun Zhang; Chunming Xie
Journal:  Front Mol Neurosci       Date:  2017-09-14       Impact factor: 5.639

7.  Potential metabolic monitoring indicators of suicide attempts in first episode and drug naive young patients with major depressive disorder: a cross-sectional study.

Authors:  Ke Zhao; Siyao Zhou; Xiang Shi; Jianjun Chen; Yaoyao Zhang; Kaili Fan; Xiangyang Zhang; Wei Wang; Wei Tang
Journal:  BMC Psychiatry       Date:  2020-07-28       Impact factor: 3.630

8.  The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety.

Authors:  Yinghua Zhong; Manji Hu; Qiang Wang; Zhendong Yang; Na Zhu; Fei Wang; Xiyan Zhang; Chengfang Zhang; Jie Min; Hao Wang; Fazhan Chen; Xudong Zhao; Xiangyang Zhang
Journal:  Sci Rep       Date:  2021-02-08       Impact factor: 4.379

9.  The association of clinical correlates, metabolic parameters, and thyroid hormones with suicide attempts in first-episode and drug-naïve patients with major depressive disorder comorbid with anxiety: a large-scale cross-sectional study.

Authors:  Yongjie Zhou; Wenchao Ren; Qianqian Sun; Katherine M Yu; Xiaoe Lang; Zezhi Li; Xiang Yang Zhang
Journal:  Transl Psychiatry       Date:  2021-02-04       Impact factor: 7.989

10.  Risk Factors for Anxiety in Major Depressive Disorder Patients.

Authors:  Li-Min Xin; Lin Chen; Zhen-Peng Ji; Suo-Yuan Zhang; Jun Wang; Yan-Hong Liu; Da-Fang Chen; Fu-De Yang; Gang Wang; Yi-Ru Fang; Zheng Lu; Hai-Chen Yang; Jian Hu; Zhi-Yu Chen; Yi Huang; Jing Sun; Xiao-Ping Wang; Hui-Chun Li; Jin-Bei Zhang; Tian-Mei Si
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-12-31       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.